The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.50 (2.86%)
Spread: 1.00 (5.714%)
Open: 17.50
High: 18.00
Low: 17.50
Prev. Close: 17.50
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of GM and Directorate Change

18 Nov 2013 12:53

CERES MEDIA INTERNATIONAL PLC - Notice of GM and Directorate Change

CERES MEDIA INTERNATIONAL PLC - Notice of GM and Directorate Change

PR Newswire

London, November 18

Ceres Media International plc (To be renamed Ducat Ventures plc) ("the Company") Result of GM and Directorate Change Results of GM At the General Meeting of the Company held earlier today all resolutions wereduly passed. As a consequence, the Company has disposed of its wholly ownedsubsidiary Ceres Media plc, and as a result will now be classified as anInvesting Company pursuant to AIM Rule 15. The Company's investing policy isset out below. Highlights * Adam Reynolds and Nicholas Nelson appointed to the Board * Name to be changed to Ducat Ventures Plc * Completion of Placing raising £285,000 * Appointment of Peterhouse Corporate Finance Limited as sole broker Directorate Change The Company announces following the General Meeting that Leslie Barber, AlexDowdeswell and Clive Garston have resigned as directors of the Company and thatAdam Reynolds and Nicholas Nelson have been appointed as directors withimmediate effect. Adam Reynolds (aged 51) - Executive Chairman Mr Reynolds is a former stockbroker, specialising in corporate finance. In 2000Mr Reynolds set up Hansard Group and listed it on AIM in 2001. Through, areverse takeover, this became First Africa Oil and Gas Limited, one of the mostsuccessful listings on AIM in 2005. Since then Mr Reynolds has built, rescuedand re-financed a number of AIM companies including; Table Mountain Minerals/Plectrum Petroleum Limited which was sold to Cairn Energy in 2007, Cielo/Curidium Medica Limited which was acquired by Avacta, International BrandLicensing the owner of the Admiral sportswear brand, which has become EKFDiagnostics Holdings Plc and Medavinci which is now Orogen Gold plc. MrReynolds is currently a director of EKF Diagnostics Holdings Plc, Orogen GoldPlc, Hubco Investments PLC and Diablo Consulting Limited and Chairman ofAutoclenz Limited. Current Directorships and Partnerships Directorships and Partnerships in the past 5 years Hansard Corporate Limited Wilton International Consulting Limited Alan Bailey (Studios) Limited Porta Communication Plc EKF Diagnostics Holdings Plc Diablo Consulting Limited Boldwood Limited Marlwood Plc Wilton International Marketing Limited Hub Capital Partners Limited Orogen Gold Plc Maidborough Limited Biolustre UK Ltd Charlton Consulting Limited Emotion Fitness Limited Hansard Group Limited Medavinci Gold Limited Wilton International Management Group Reyco Limited TSE Brands Limited Hubco Investments Plc Wallgate Group Plc Autoclenz Group Limited BCOMP 415 Limited Following the General Meeting and Placing Adam Reynolds has an interest over79,196,667 ordinary shares representing approximately 9% of the issued sharecapital of the Company. In July 2008 Adam Reynolds was appointed as a Non-executive Director toWallgate Plc and resigned in November 2008. Administrators were appointed toWallgate plc in January. The estimated deficit to creditors was £419,000 In 1995, Adam Reynolds was appointed as a Non-executive Director of GreenhillsPlc and resigned in January 1996. Greenhills Plc was placed into compulsoryliquidation in March 1997, following the appointment of receivers in December1996. Liquidators estimated that the deficit to secured creditors was in excessof £300,000. There are no further matters that require disclosure in relation to Mr Reynoldspursuant to Schedule 2 (g) of the AIM rules. Nicholas Christian Paul Nelson (aged 48) - Non-Executive Director Mr Nelson's career spans 30 years commencing in the mid 1980s as a juniordealer on the floor of the London Stock Exchange, through investment managementand into financial Public Relations for 13 years. Accordingly, he has developeda close working knowledge of the stock market, its drivers and administrativechallenges. With his broad knowledge he has assisted on several AIM and ISDX flotationsproviding logistical and PR support and has been appointed to the board ofnumerous early stage public companies as part of their admission to the publicmarkets. In all, he has held directorships with six publicly quoted companiesprincipally, to represent their interests in the City and amongst investorsduring periods of corporate change. Mr Nelson remains on the board of Adams Plcand is Chairman of ISDX quoted Equatorial Mining and Exploration Plc, aninvestment company in the minerals sector. Current Directorships and Partnerships Directorships and Partnerships in the past 5 years Adams Plc Hansard Communications Ltd Equatorial Mining and Exploration Plc DotDigital Group Plc Nexus Financial Ltd Haggie Nelson LLP NN Limited Special Risk Insurance Brokers Ltd Nexfin Limited Rare Minerals Plc Charlton Consulting Ltd Charzor Plc Following the General Meeting and Placing Nicholas Nelson has an interest over50,000,000 ordinary shares representing approximately 6% of the issued sharecapital of the Company. In 1997 a winding-up order was made against the Multimedia Factory (UK) Limitedand administered by the Official Receiver. The deficiency as regards creditorswas £44,014 and as these amounts were principally directors' loans andexpenses, no further action was taken and the company was dissolved. Nexfin Limited was incorporated on 14 October 2010 to reserve the name. Itnever traded and was dissolved some months later. There are no further matters that require disclosure in relation to Mr Nelsonpursuant to Schedule 2 (g) of the AIM rules. Change of Name Shareholders have approved that the Company changes its name to Ducat Venturesplc, a new TIDM "DVC" has been applied for and will become active once a changeof name certificate has been granted by Companies House. Share Capital Reorganisation Following the approval of the share capital reorganisation the par value of theordinary shares of the Company is £0.0001. The Company's ISIN and SEDOL remainunchanged as a result of the share capital reorganisation. Placing The Company has raised £285,000 through the issue of 712,500,000 new ordinaryshares at a price of £0.0004 per share. The net proceeds of the placing will beused for general working capital purposes. Application has been made to the London Stock Exchange for the 895,237,295 newordinary shares to be admitted to trading on AIM. Trading in these shares isexpected to commence on or around 8.00 am on 19 November 2013. The new ordinaryshares will rank pari passu with the existing ordinary shares. Appointment of Broker The Company announces that Peterhouse Corporate Finance Limited has beenappointed as sole broker with immediate effect. Investing Policy The Company's proposed Investing Policy is that the Company will either acquireor invest in a business or businesses which have some or all of the followingcharacteristics: * strong management with a proven track record; * ready for investment without the need for material re-structuring by the Company; * generating positive cash flows or imminently likely to do so; * via an injection of new finances or specialist management, the Company can enhance the prospects and therefore the future value of the investment; * able to benefit from the Proposed Directors existing network of contacts; and * the potential to deliver significant returns for the Company. The Company will focus on opportunities within a range of high growth sectorsworldwide such as natural resources, technology and life sciences. Moreover, the criteria set out above are not intended to be exhaustive and theProposed Directors may make an investment which does not fulfil any or all ofthe investment criteria if they believe it is in the best interests ofShareholders as a whole. Whilst the Proposed Directors will be principally focused on making aninvestment in private businesses, they would not rule out investment in listedbusinesses if this presents, in their judgment, the best opportunity forShareholders. The Company intends to be an active investor in situations where the Companycan make a clear contribution to the progress and development of theinvestment. In respect of other, more substantial investment opportunities, theProposed Directors expect that the Company will be more of a passive investor. The Proposed Directors believe that their broad collective experience togetherwith their extensive network of contacts will assist them in theidentification, evaluation and funding of appropriate investment opportunities.When necessary, other external professionals will be engaged to assist in thedue diligence on prospective targets and their management teams. The ProposedDirectors will also consider appointing additional directors with relevantexperience if required. There will be no limit on the number of projects into which the Company mayinvest, and the Company's financial resources may be invested in a number ofpropositions or in just one investment, which may be deemed to be a reversetakeover pursuant to Rule 14 of the AIM Rules. Where the Company builds aportfolio of related assets it is possible that there may be cross-holdingsbetween such assets. The Company does not currently intend to fund anyinvestments with debt or other borrowings but may do so if appropriate. Investments may be made in all types of assets and there will be no investmentrestrictions. The Company's primary objective is that of securing for the Shareholders thebest possible value consistent with achieving, over time, both capital growthand income for Shareholders through developing profitability coupled withdividend payments on a sustainable basis. Change of Rule 26 website address To reflect the Company's new name its Rule 26 website address will change towww.ducatventures.co.uk when the Company receives its change of namecertificate, until that time the Company's Rule 26 website address will remainas www.ceresmediaplc.com. Total Voting Rights In accordance with the Disclosure and Transparency Rules (DTR 5.6.1R) theCompany hereby notifies the market that immediately following Admission itsissued share capital will consist of 895,237,295 ordinary shares of £0.0001.The Company does not hold any shares in treasury. Shareholders may use thisfigure as the denominator for the calculations by which they will determine ifthey are required to notify their interest in, or a change to their interestin, the Company under the FCA's Disclosure and Transparency Rules. For further information, please contact: Ceres Media International plc Nicholas Nelson +44 (0)79 2152 2920 Cairn Financial Advisers LLP Liam Murray / Jo Turner +44 (0)20 7148 7900 Peterhouse Corporate Finance Lucy Williams/ Fungai Ndoro +44 (0)20 7469 0936Ltd
Date   Source Headline
10th May 20247:00 amRNSInvestor update
30th Apr 20247:00 amRNSManufacturing agreement with KAG Industries
15th Apr 20248:49 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSPlacing, Subscription and Director Dealing
18th Mar 202411:36 amRNSHolding(s) in Company
13th Mar 20247:00 amRNSPartnership agreement with Morepen for SlimBiome
8th Mar 20244:09 pmRNSHolding(s) in Company
27th Feb 20247:00 amRNSStrategic and commercial update
9th Feb 20247:00 amRNSChange of auditor
5th Feb 20247:00 amRNSPresentation at ProBiota 2024
30th Jan 20247:00 amRNSSweetBiotix Update
15th Jan 20247:00 amRNSLaunch of LeanBiome in Muscletech
4th Dec 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSDistribution agreement for SlimBiome
24th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSBBSRC Grant for WellBiome®
1st Nov 20237:00 amRNSCommercial update
23rd Oct 20237:00 amRNSLicense agreement with Tata Chemicals
19th Oct 20233:02 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSPlanned launch of OptiBiotix products with Boots
29th Aug 20237:00 amRNSCommercial update
31st Jul 202312:51 pmRNSHolding(s) in Company
26th Jul 202312:34 pmRNSResult of AGM
19th Jul 20237:00 amRNSSweetBiotix® overview
28th Jun 20237:00 amRNSFinal Results
4th May 20237:00 amRNSInvestor update
21st Mar 20237:00 amRNSChange of Broker
15th Mar 20237:00 amRNSSlimbiome study results
21st Feb 20237:00 amRNSDirectorate Change
30th Jan 20234:28 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIssue of Equity – Subscription
10th Nov 202211:30 amRNSInvestor update
1st Nov 20227:00 amRNSLaunch of GoFigure products on Tmall China
24th Oct 20227:00 amRNSApproval of GoFigure products
17th Oct 20227:00 amRNSNew health claims for SlimBiome in Australia
17th Oct 20227:00 amRNSNew health claims for SlimBiome in Australia
28th Sep 20227:00 amRNSHalf-year Report
26th Sep 20227:00 amRNSLaunch of novel prebiotic in Europe and Africa
20th Sep 20227:00 amRNSLaunch of GoFigure range with Apollo Hospitals
14th Sep 20227:00 amRNSNew commercialisation partner in Asia Pacific
24th Aug 20224:41 pmRNSSecond Price Monitoring Extn
24th Aug 20224:35 pmRNSPrice Monitoring Extension
24th Aug 20222:06 pmRNSSecond Price Monitoring Extn
24th Aug 20222:00 pmRNSPrice Monitoring Extension
24th Aug 202211:06 amRNSSecond Price Monitoring Extn
24th Aug 202211:00 amRNSPrice Monitoring Extension
24th Aug 20229:05 amRNSSecond Price Monitoring Extn
24th Aug 20229:00 amRNSPrice Monitoring Extension
24th Aug 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.